Related Experiment Video

Updated: May 7, 2026

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery
13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

4.2K

[Monoclonal antibody therapy in breast cancer]

Magdolna Dank1, Tímea Tõkés

  • 1I. Sz. Belgyógyászati Klinika, Semmelweis Egyetem, Onkológiai Részleg, Budapest, Hungary.

Magyar Onkologia
|October 11, 2013
PubMed

Insights

Personalized medicine is revolutionizing oncology, especially breast cancer treatment. Molecular insights guide targeted therapies, improving outcomes in various stages of the disease.

Area of Science:

  • Oncology
  • Molecular Pathology
  • Personalized Medicine

Background:

  • The last two decades have seen a shift towards individualized cancer treatments.
  • Breast cancer management exemplifies the success of personalized therapeutic strategies.
  • Molecular pathology now informs treatment decisions based on tumor biology.

Purpose of the Study:

  • To review current monoclonal antibody therapies for breast cancer.
  • To explore emerging research and future directions in antibody-based breast cancer treatment.

Main Methods:

  • Literature review of monoclonal antibodies in breast cancer treatment.
  • Analysis of current research trends and future prospects.

Main Results:

  • Monoclonal antibodies are integral to personalized breast cancer therapy.
  • Molecular profiling enhances the efficacy of targeted treatments.
  • Ongoing research promises novel antibody-based therapeutic approaches.

Conclusions:

  • Individualized treatment strategies, particularly using monoclonal antibodies, are transforming breast cancer care.
  • Advances in molecular pathology are key to optimizing these personalized approaches.
  • Future research directions focus on expanding the utility of antibody therapies in oncology.

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

4.9K
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

8.9K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K